Skip to content
Private Equity FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 10 SOURCES

Quadriga Capital

Also known as Quadriga Capital Eigenkapitalberatung GmbH, Quadriga Capital Funds

Frankfurt mid-market private equity firm advising the Quadriga Capital Funds; majority stakes in DACH healthcare, tech-enabled services and smart industries companies; €20–120m equity tickets.

Frankfurt mid-market private equity adviser to the Quadriga Capital Funds. Not Quadriga Fintech or QuadrigaCX.

HEADQUARTERS
Frankfurt am Main, Germany
FOUNDED
—
OUTSIDE CAPITAL
Yes
TEAM LISTED
18 people

Focus

STAGES
GrowthBuyout
ASSET MIX
Private equityImpact
GEOGRAPHY
GermanyAustriaSwitzerlandEurope

Overview

Quadriga Capital advises the Quadriga Capital Funds, which take mainly majority stakes in owner-led mid-sized companies in Germany, Austria, Switzerland and neighbouring countries. Its founders around Dr. Andreas Fendel and Max W. Römer helped establish private equity in Germany in the mid-1980s, and it says the funds have backed more than 150 mid-sized growth companies, with more than 50 international institutional investors. It focuses on Healthcare, Tech-Enabled Services and Smart Industries, often via platform and buy-and-build strategies, and publishes sustainability reports as a signatory of the Operating Principles for Impact Management.

Investment thesis

Builds market leaders organically or by buy-and-build in Healthcare, Tech-Enabled Services and Smart Industries: established DACH mid-market companies with €50–300m revenue and €50–250m enterprise value, in megatrend-supported markets with digital-transformation potential and a positive environmental and social impact; mainly majority stakes, qualified minorities in exceptions.

PORTFOLIO (24)

  • GBA GroupNOTABLE
    HealthTech
  • SCIO AutomationNOTABLE
    Industrial & Manufacturing
  • salestech group
    Software & SaaS
  • HealthTech
  • Newcare
    HealthTech
  • GIG Gesellschaft für integrierte Gesundheitsversorgung
    HealthTech
  • Ipsen
    Industrial & Manufacturing
  • Kinetics
    Industrial & Manufacturing · Exited
  • Aspire Education
    Education · Exited
  • Alicona
    Industrial & Manufacturing · Exited
  • M+R Automation
    Industrial & Manufacturing · Exited
  • Krankenhausgruppe
    HealthTech · Exited
  • Dorea Familie
    HealthTech · Exited
  • AHT
    Industrial & Manufacturing · Exited
  • LEWA Pumps & Systems
    Industrial & Manufacturing · Exited
  • Lapp Insulators
    Industrial & Manufacturing · Exited
  • Punker
    Industrial & Manufacturing · Exited
  • Coventya
    Industrial & Manufacturing · Exited
  • Essmann
    Industrial & Manufacturing · Exited
  • Francotyp-Postalia
    Industrial & Manufacturing · Exited
  • Saia-Burgess Controls
    Industrial & Manufacturing · Exited
  • Uster
    Industrial & Manufacturing · Exited
  • ZTK Zahngesundheit
    HealthTech · Exited
  • Hedrich Group
    Industrial & Manufacturing · Exited

People

  • Philipp Jacobi
    Managing Partner · source
  • Jörg Mugrauer
    Managing Partner · source
  • Dr. Philip Matlachowsky
    Partner · source
  • Thomas Render
    Partner · source
  • Sven Hoffmann
    Director · source
  • Deniz Varan
    Senior Investment Manager · source
  • Philipp Rosenbach
    Investment Manager · source
  • Dr. Violetta Sulzbach
    Sustainability & Operations Manager · source
  • Jasper von Richthofen
    Chief Operating Officer · source
  • Dr. Marina Martini
    Chairwoman Healthcare Board · source
  • Norbert Müller
    Chairman Senior Executive Board · source
  • Prof. Dr. Herwig Buchholz
    Chairman Impact Advisory Board · source
  • Prof. Dr. Thomas Bauernhansl
    Chairman Digital Board · source
  • Reinhard Schings
    Healthcare Board · source
  • Jan Weidner
    Senior Advisor · source
  • Alice Drooghmans
    Impact Advisory Board · source
  • Joanna Radeke
    Impact Advisory Board · source
  • Prof. Dr. Torsten Kröger
    Digital Board · source

Links

Frequently asked questions

Quadriga Capital is a private equity fund based in Frankfurt am Main, Germany.

Yes. Quadriga Capital invests its own capital in private companies.

Quadriga Capital invests at Growth and Buyout stages in HealthTech, Software & SaaS and Industrial & Manufacturing.

Quadriga Capital's stated ticket size is €20M–€120M.

Key people at Quadriga Capital include Philipp Jacobi (Managing Partner), Jörg Mugrauer (Managing Partner), Dr. Philip Matlachowsky (Partner) and Thomas Render (Partner).

Quadriga Capital's investments include GBA Group, SCIO Automation, salestech group, UNITED THERAPY, Newcare, GIG Gesellschaft für integrierte Gesundheitsversorgung, Ipsen and Kinetics, among others.

The most recent publicly reported investment by Quadriga Capital is Johner Institut (add-on to GBA Group) (Add-on acquisition), announced in Mar 2026.

Yes. Quadriga Capital manages capital from outside investors.